Market Value339,791,000
Total Holdings46
File Date2018-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CNCE / Concert Pharmaceuticals Inc
GTHX / G1 Therapeutics, Inc.
/ Immunomedics, Inc.
LCI / Lannett Co., Inc. Call
IOVA / Iovance Biotherapeutics, Inc.
BDSI / Biodelivery Sciences International
LCI / Lannett Co., Inc.
ACOR / Acorda Therapeutics, Inc.
AVRO / AVROBIO, Inc.
KDMN / Kadmon Holdings Inc
AVDL / Avadel Pharmaceuticals plc
KPTI / Karyopharm Therapeutics Inc.
INFI / Infinity Pharmaceuticals Inc.
US64052L1061 / Neos Therapeutics, Inc.
BOLD / Boundless Bio, Inc.
OBSV / ObsEva SA.
KDNY / Chinook Therapeutics Inc
ADMS / Adamas Pharmaceuticals Inc
DRNA / Dicerna Pharmaceuticals Inc
AVXS / AveXis, Inc.
CURRENCYSHARES SWISS FRANC T / SWISS FRANC SH (23129V109)
ECYT / Endocyte, Inc.
SPPI / Spectrum Pharmaceuticals, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
NBRV / Nabriva Therapeutics Plc
NLTX / Neoleukin Therapeutics, Inc.
KURA / Kura Oncology, Inc.
ASMB / Assembly Biosciences, Inc.
ANAB / AnaptysBio, Inc.
CBIO / Crescent Biopharma, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
GNCA / Genocea Biosciences Inc
GBT / Global Blood Therapeutics Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
EXEL / Exelixis, Inc.
018490100 / Allergan plc
CLVS / Clovis Oncology Inc
JNCE / Jounce Therapeutics Inc
GLYC / GlycoMimetics, Inc.
US00C4U1L353 / Mylan N.V.
PDSB / PDS Biotechnology Corporation
ARGX / argenx SE - Depositary Receipt (Common Stock)
MOTS / Motus GI Holdings, Inc.
TVTX / Travere Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
MRSN / Mersana Therapeutics, Inc.
TCDA / Tricida Inc
MDGL / Madrigal Pharmaceuticals, Inc.
INCY / Incyte Corporation Put
BLUE / bluebird bio, Inc.
TSRO / TESARO, Inc.
SAGE / Sage Therapeutics, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
BHVN / Biohaven Ltd.
BHVN / Biohaven Ltd. Call
IMGN / ImmunoGen, Inc.
VRAY / ViewRay Inc.
PBYI / Puma Biotechnology, Inc.
MRTX / Mirati Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
ACAD / ACADIA Pharmaceuticals Inc.
TGTX / TG Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
SRPT / Sarepta Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.